New Delhi: Premium condom market industry is in panic mode as drug pricing authority has set price cap of Rs. 6.50. According to industry reports, premium condom market in India is already one-fifth of the global pricing. If the drug pricing order stays than many features of premium condoms will vanish and no more innovative products will be introduced in India because of the cost factor.
According to a report in The Economic Times, the manufacturers are not taking this lying down. Almost all the companies that sell premium prophylactics - TTK Protective Devices (Skore), JK Ansell (KamaSutra), Reckitt Benckiser (Durex, Kohinoor) and Mankind (Manforce) - have challenged the condom pricing order of the National Pharma Pricing Authority (NPPA), a government official told ET.
No comments:
Post a Comment